Customs Classification Of Biological Materials In Russia.
1. Introduction
Customs classification of biological materials in Russia is an important area of international trade law, biotechnology regulation, pharmaceutical law, public health law and customs administration.
Biological materials may include human blood, tissues, organs, embryos, reproductive cells, stem cells, microorganisms, bacteria, viruses, animal specimens, biological samples and laboratory materials. These products are frequently transported across international borders for medical treatment, transplantation, fertility treatment, scientific research, pharmaceutical manufacturing, genetic testing and clinical trials.
The central legal issue is determining the correct customs classification of a biological material when it enters or leaves the Russian Federation.
Incorrect classification can result in:
Customs delays and seizure of consignments.
Incorrect customs duties and tax assessments.
Refusal to release biological materials.
Violation of import or export licensing requirements.
Administrative penalties.
Export-control investigations.
Potential criminal liability where the relevant statutory elements are established.
Russia's customs classification system operates within the Eurasian Economic Union (EAEU) framework. Therefore, customs classification is principally governed by the EAEU Commodity Nomenclature for Foreign Economic Activity (TN VED EAEU), the EAEU Customs Code and applicable decisions of the Eurasian Economic Commission.
An important distinction must be maintained: customs classification and regulatory permission are separate legal questions. A biological material may have a correctly declared customs code but still require a licence, regulatory approval or export-control authorization.
2. Legal Framework Governing Biological Materials
The principal legal instruments include the following.
| Legal instrument | Legal significance |
|---|---|
| EAEU Customs Code | Establishes customs declaration, classification, verification and release procedures |
| EAEU TN VED | Provides the customs classification system |
| EEC Board Decision No. 30 of 21 April 2015 | Establishes non-tariff regulation measures, including rules for human organs, tissues, blood and biological samples |
| Federal Law No. 289-FZ of 3 August 2018 | Regulates customs administration in Russia |
| Federal Law No. 183-FZ of 18 July 1999 | Regulates export control |
| Federal Law No. 323-FZ of 21 November 2011 | Establishes the general legal framework for healthcare |
| Federal Law No. 180-FZ of 23 June 2016 | Regulates biomedical cellular products |
The most important instrument for human biological materials is EEC Board Decision No. 30 of 21 April 2015, particularly Section 2.21 of the unified list and its associated regulatory provisions.
The decision identifies human organs and tissues, blood and blood components, and human biological samples as categories subject to specific non-tariff regulatory requirements. Its provisions have been amended, including by Decision No. 69 of 18 June 2024, effective from 21 July 2024.
Consultant Plus+2
3. Meaning and Scope of Biological Materials
For customs purposes, biological materials must be identified according to their actual characteristics, composition, origin, condition and intended use.
A. Human biological materials
These include:
Human blood and blood components.
Human organs.
Human tissues.
Bone marrow.
Haematopoietic stem cells.
Reproductive cells.
Human embryos.
Human cell samples.
Biological fluids.
Histological and pathological specimens.
Under the EAEU regulatory framework, human biological samples include cells, tissues, biological fluids, secretions, products of human activity, physiological and pathological discharges, swabs, scrapings and washings used for diagnostic or scientific purposes, quality-control studies or obtained during biomedical and clinical research.
ГАРАНТ+1
B. Animal biological materials
These include:
Animal blood.
Animal tissues.
Veterinary vaccines.
Animal embryos.
Animal organs.
Pathological specimens.
Animal-derived pharmaceutical substances.
Biological products used in veterinary research.
Their classification may depend on whether they are intended for veterinary diagnosis, pharmaceutical production, scientific research or another commercial purpose.
C. Microorganisms and biological cultures
Examples include:
Bacteria.
Fungi.
Viral cultures.
Microbial strains.
Laboratory cultures.
Biological reference materials.
These materials may fall under different customs headings depending on their precise nature and preparation.
D. Pharmaceutical and biotechnology materials
Examples include:
Vaccines.
Immunological products.
Antisera.
Blood fractions.
Cell-based medicinal products.
Biological pharmaceutical preparations.
A biological material does not automatically become a pharmaceutical product merely because it is used in medical research.
4. Customs Classification Under the TN VED EAEU
The TN VED EAEU provides the legal framework for identifying the customs classification of imported and exported goods.
Classification generally requires consideration of:
The physical characteristics of the product.
Its biological origin.
Its composition.
Its processing or preservation.
Whether it is living, frozen, preserved or prepared.
Its intended purpose, where relevant under the applicable heading.
The General Rules for Interpretation of the nomenclature.
Relevant section and chapter notes.
The following headings are particularly important.
| TN VED heading | General subject matter |
|---|---|
| 0511 | Animal products not elsewhere specified or included |
| 3001 | Certain human or animal glands, organs and other specified products |
| 3002 | Blood, antisera, immunological products, vaccines and cultures of microorganisms |
| 3822 | Diagnostic or laboratory reagents and certain prepared diagnostic materials |
These are indicative headings, not automatic classifications. The precise subheading must be determined from the actual product and applicable nomenclature.
A. Heading 0511: Animal products and certain biological specimens
Heading 0511 may be relevant to certain biological materials of animal origin and other products covered by its wording.
B. Heading 3001: Organs, tissues and related products
Heading 3001 is particularly relevant to certain human or animal organs, glands and other specified products.
Under Section 2.21 of Decision No. 30, various human organs and tissues, including reproductive cells and embryos, are identified under code 3001 90 200 0.
C. Heading 3002: Blood and immunological products
Heading 3002 covers, among other things:
Human blood.
Animal blood prepared for therapeutic, prophylactic or diagnostic uses.
Antisera.
Certain blood fractions.
Immunological products.
Vaccines.
Toxins.
Cultures of microorganisms.
Different subheadings apply according to the product's characteristics.
D. Heading 3822: Diagnostic and laboratory reagents
This heading may be relevant to prepared diagnostic or laboratory reagents, including certain materials involving biological components.
A laboratory sample and a prepared diagnostic reagent must not be treated as interchangeable customs categories.
5. Classification of Human Biological Samples Under Section 2.21
Section 2.21 of the EAEU unified list is especially important because it specifically addresses human organs, tissues, blood and biological samples.
The listed categories include:
| Biological material | Indicative TN VED EAEU code |
|---|---|
| Certain human organs and tissues | 3001 90 200 0 |
| Human reproductive cells and embryos | 3001 90 200 0 |
| Human biological samples | Several codes, depending on their nature |
| Human blood and blood components | Relevant subheadings of 3002 |
| Certain human biological samples | 0511 99 853 9 |
| Certain human biological samples | 0511 99 859 9 |
| Certain human biological samples | 3002 12 000 5 |
| Certain human biological samples | 3002 13 000 0 |
| Certain human biological samples | 3002 14 000 0 |
| Certain human biological samples | 3002 90 100 0 |
The list expressly provides that classification must take account of both the TN VED code and the description of the goods. Therefore, selecting a code solely because it appears in a biological-material category is insufficient.
sudact.ru+1
Important legal distinction
For example, a frozen human oocyte intended for fertility treatment and a histological tissue sample intended for cancer research may both be biological materials, but their classification and regulatory treatment can differ.
The customs authority must examine the actual identity and intended use of the product rather than relying exclusively on a general description such as "biological sample."
6. Import Requirements for Biological Materials into Russia
The importation of biological materials into Russia may involve customs clearance, licensing, medical regulatory requirements, sanitary controls and other permissions.
A. Import declaration
The importer must provide accurate information concerning:
Product description.
Customs classification code.
Country of origin.
Quantity and weight.
Commercial value.
Intended purpose.
Packaging and preservation conditions.
Consignor and consignee.
Relevant permits and certificates.
B. Regulatory permissions
Depending on the material, authorities may require:
Import licences.
Regulatory conclusions.
Veterinary certificates.
Sanitary or epidemiological documentation.
Documents confirming medical or scientific purposes.
Export-control or other specialized authorizations.
For human organs, tissues, blood and relevant biological samples, the requirements under Decision No. 30 must be examined.
C. Role of Roszdravnadzor
The Federal Service for Surveillance in Healthcare (Roszdravnadzor) has an important role in the regulatory administration of relevant human biological materials.
The Ministry of Industry and Trade (Minpromtorg) is also involved in licensing certain categories.
The precise requirements depend on the material, the direction of movement and the purpose of the shipment.
58reg.roszdravnadzor.ru+1
7. Export Classification and Export-Control Restrictions
Exportation of biological materials from Russia can raise more complicated legal issues than ordinary customs classification.
The reason is that some biological samples may have applications beyond ordinary medical or scientific research.
For example:
Genetic research.
Pathogen identification.
Microbiological research.
Biological weapons-related research.
Advanced biotechnology.
Defence-related scientific development.
Federal Law No. 183-FZ establishes the Russian export-control framework.
The relevant legal question is whether the exported material falls within a controlled category and whether an applicable exemption exists.
A. Medical and diagnostic purposes
Biological materials intended for genuine medical and diagnostic purposes may fall within exceptions to certain dual-use export-control requirements.
However, a medical or diagnostic description on an invoice is not necessarily sufficient proof.
B. Scientific and research purposes
Samples intended for research may require additional scrutiny.
The exporter should establish:
The exact scientific purpose.
The identity of the receiving laboratory.
The nature of the biological material.
The applicable export-control classification.
Whether a licence or authorization is required.
C. Dual-use biological materials
Some biological materials can have both peaceful and potentially military applications.
The export-control analysis must therefore be conducted separately from the customs tariff classification.
The WTO's published information on Russia's restrictions concerning human organs, tissues, blood and biological samples identifies the EAEU Decision No. 30 framework and the involvement of Minpromtorg and Roszdravnadzor in the relevant licensing process.
WTO Quantitative Restrictions+1
8. Customs Valuation and Documentation
Customs classification is closely connected with customs valuation, but these are separate legal processes.
For commercial shipments, customs value may affect the calculation of import duties and taxes.
However, biological materials can present special valuation difficulties.
For example:
Donated human tissues may have no ordinary commercial sale price.
Research samples may be supplied under a collaborative agreement.
Clinical-trial materials may be supplied without a conventional sale.
Reproductive cells may be transported under a fertility-treatment agreement.
Biological specimens may be transferred between affiliated laboratories.
The customs declaration must reflect the applicable valuation rules rather than assuming that a zero-price invoice means zero customs value.
Important supporting documents
An exporter or importer should generally maintain:
Commercial invoice or pro forma invoice.
Packing list.
Transportation documents.
Material identification certificate.
Laboratory description.
Certificate of origin, where applicable.
Medical or research-purpose documentation.
Relevant import or export authorization.
Preservation and temperature records.
Scientific or technical specifications.
For frozen biological materials, temperature records and container specifications may also help establish the product's physical condition.
9. Customs Classification Disputes and Judicial Review
Classification disputes commonly arise when customs authorities disagree with the declared code or consider that the importer or exporter has incorrectly described the material.
The principal issues include:
Whether a sample is a human biological specimen or a pharmaceutical preparation.
Whether a product belongs under heading 3001 or 3002.
Whether the material is intended for medical diagnosis or scientific research.
Whether the shipment is subject to export control.
Whether the correct authorization was obtained.
Whether the customs declaration accurately describes the material.
Russian arbitrazh courts review customs decisions under the applicable customs and administrative law framework.
The following cases are particularly useful.
10. Important Russian Case Laws
The following decisions concern actual disputes involving human biological materials, export classification and regulatory restrictions. They should be distinguished from judicial decisions establishing a universal tariff classification rule.
Case 1: ООО «СтарЭксперт» — Case No. А56-36287/2023
Important customs precedent
Court decision: 7 March 2024.
Facts:
A Russian company exported human biological samples for research purposes to a British recipient, CREATE FERTILITY.
The samples were declared under TN VED EAEU code 3001 90 200 0.
The exporter described the materials as human biological samples for research, not intended for veterinary purposes and not constituting medicines or pharmaceutical substances.
The goods were initially released under the export procedure.
Subsequently, customs authorities conducted a post-release examination and considered the materials in the context of Russian dual-use export-control legislation.
Legal issue:
Whether the export of human biological samples required compliance with export-control requirements in addition to the ordinary customs declaration and healthcare-related documentation.
Judicial significance:
The case demonstrates that customs release does not necessarily prevent a subsequent investigation into compliance with export-control requirements.
It also illustrates that biological materials must be evaluated according to their actual characteristics and applicable regulatory restrictions.
Legal principle: Customs clearance and export-control compliance are separate obligations.
sudact.ru
Case 2: Case No. А56-36285/2023
Court decision: 20 November 2023.
Facts:
A company exported human biological materials under customs declaration No. 10228010/211021/0501999.
The materials were declared under code 3002 12 000 5.
The exporter relied on a Roszdravnadzor conclusion and described the purpose as diagnostic research.
Customs authorities questioned whether the submitted documentation adequately established that the materials were intended for therapeutic and diagnostic purposes.
Legal issue:
Whether a Roszdravnadzor conclusion alone was sufficient to establish that the exported samples fell within an applicable medical-purpose exception to export-control restrictions.
Judicial significance:
The dispute illustrates that possession of a healthcare regulatory document does not automatically establish exemption from export-control legislation.
The intended purpose of the biological materials must be supported by appropriate evidence.
Legal principle: Regulatory permission and proof of the purpose of export must be assessed separately.
sudact.ru
Case 3: Case No. А56-36284/2023
Court decision: 20 June 2024.
Facts:
The dispute concerned frozen human biological materials declared for export to Belgium.
The consignment included histological cassettes containing human tissue samples from patients with non-small-cell lung cancer.
The declaration included a customs code associated with heading 3002.
The customs authorities examined the relationship between the samples, their declared purpose and the regulatory classification of human reproductive cells and embryos under Section 2.21.
Legal issue:
Whether the declared biological materials were adequately documented as being intended for medical and diagnostic purposes and whether export-control requirements applied.
Judicial significance:
The case demonstrates the importance of accurately distinguishing histological specimens, reproductive materials and other human biological samples.
The description of the product in the declaration must correspond to its actual biological identity.
Legal principle: The legal classification of a biological specimen depends on its actual nature and applicable regulatory category, not simply on a broad commercial description.
sudact.ru
Case 4: Case No. А56-36289/2023
Court decision: 27 February 2024.
Facts:
The dispute concerned frozen human oocytes exported to Singapore.
The materials were transported in cryogenic containers at approximately minus 196°C.
The exporter declared the goods under code 3001 90 200 0 and provided a Roszdravnadzor conclusion.
The customs authorities considered the application of export-control legislation and the exception for biological materials intended for therapeutic and diagnostic purposes.
Legal issue:
Whether the medical or fertility-related purpose of the shipment was sufficiently established to justify the claimed regulatory treatment.
Judicial significance:
The case is important for international fertility clinics, reproductive biotechnology companies and exporters of cryopreserved reproductive materials.
It demonstrates that reproductive cells may require both correct customs identification and evidence supporting the declared purpose of export.
Legal principle: Cryogenic preservation and a healthcare-related authorization do not, by themselves, eliminate the need to examine export-control requirements.
sudact.ru
Case 5: Case No. А56-36286/2023
Court decision: 12 March 2024.
Facts:
The dispute concerned frozen human oocytes exported for diagnostic research to a fertility laboratory in Hong Kong.
The materials were transported in a cryogenic container using liquid nitrogen at approximately minus 196°C.
The exporter declared the goods under code 3001 90 200 0.
A Roszdravnadzor conclusion was also presented.
Legal issue:
Whether the regulatory documentation and declared medical purpose were sufficient to satisfy the applicable export-control requirements.
Judicial significance:
The case provides an example of the legal difficulties surrounding the international transportation of reproductive biological materials.
It also illustrates why the customs description, actual product identity and intended use must be consistent.
sudact.ru
Case 6: Case No. А56-56945/2023
Court decision: 8 November 2023.
Administrative liability issue
Facts:
Customs authorities examined an export shipment of biological materials declared under code 3001 90 200 0.
Following a post-release investigation, the authorities concluded that the materials fell within the relevant dual-use export-control framework.
An administrative offence proceeding was initiated under Article 16.3 of the Russian Code of Administrative Offences.
A fine of 50,000 roubles was imposed.
The company challenged the customs decision before the arbitrazh court.
Legal issue:
Whether failure to comply with applicable export restrictions constituted an administrative offence.
Judicial significance:
The dispute illustrates that non-compliance with customs-related prohibitions and restrictions may create administrative liability even where the goods have already been released.
Legal principle: Compliance with customs declaration requirements does not replace compliance with independent export-control restrictions.
sudact.ru
Case 7: Case No. А56-36283/2023
Judicial authority: Thirteenth Arbitrazh Court of Appeal.
Decision: 26 October 2023.
Facts:
The dispute concerned the export of biological materials, including human reproductive cells.
The customs authorities considered the classification of the materials under Section 2.21 of EEC Decision No. 30 and the corresponding export-control rules.
Legal issue:
Whether the exporter had complied with the necessary requirements concerning biological materials intended for medical and diagnostic purposes.
Judicial significance:
The decision reinforces the importance of establishing the actual purpose of the export and complying with the applicable regulatory framework.
It is particularly relevant to fertility clinics and biotechnology businesses involved in cross-border transportation.
ГАРАНТ
11. Administrative and Criminal Liability
Incorrect classification or failure to comply with regulatory restrictions can produce several forms of liability.
A. Article 16.2 of the Russian Code of Administrative Offences
This provision concerns violations relating to customs declaration, including failure to declare goods or inaccurate declaration in circumstances covered by the article.
It may become relevant where an exporter incorrectly declares biological materials or supplies materially inaccurate information.
B. Article 16.3 of the Russian Code of Administrative Offences
This provision concerns non-compliance with prohibitions and restrictions on the import or export of goods.
It is particularly relevant to biological materials subject to licensing, export-control or other regulatory requirements.
The Case No. А56-56945/2023 dispute illustrates the practical application of Article 16.3 to the export of biological materials.
sudact.ru
C. Criminal liability
Criminal liability may arise where the facts satisfy the elements of an applicable criminal offence.
Potentially relevant provisions include:
Article 226.1 of the Russian Criminal Code: smuggling of specified controlled goods and resources.
Article 189: illegal export or transfer of goods, technologies, information, works or services subject to export-control restrictions, where its statutory elements are established.
Other provisions may apply to unlawful trafficking in particular biological materials.
Not every customs classification error constitutes a criminal offence. The relevant statutory elements, including the nature of the goods, conduct, intent and applicable thresholds, must be established.
12. Special Classification Issues in Emerging Biotechnology
Modern biotechnology creates new classification problems because biological materials increasingly exist in technologically modified forms.
A. Stem cells
Stem cells may be transported for transplantation, clinical trials, research or manufacturing of cellular medicinal products.
Their classification depends on their actual characteristics and applicable tariff headings.
Customs authorities should distinguish between unprocessed biological samples and processed therapeutic products.
B. Cryopreserved embryos
Cryopreserved embryos create special classification issues because they involve reproductive biotechnology and human biological material.
Section 2.21 expressly identifies reproductive cells and embryos under code 3001 90 200 0.
The exporter must also consider the separate regulatory requirements governing international movement of these materials.
C. Genetic samples and DNA specimens
DNA samples may take the form of blood, saliva, extracted DNA, prepared laboratory material or diagnostic reagents.
Their classification cannot be determined simply by the presence of genetic information.
For example, a saliva specimen containing human cells and an isolated DNA preparation may require different classification analyses.
D. Cultured meat and cellular agriculture
Cultured meat is produced through cellular agriculture and involves biological materials obtained and cultivated under controlled conditions.
Its classification may depend on whether the imported product is:
A living cell culture.
A biological growth medium.
An animal-derived ingredient.
A processed cellular product.
A finished food product.
Food safety, veterinary and customs requirements must be examined independently.
E. Genetically modified microorganisms
Genetically modified microorganisms may create additional export-control concerns.
Their classification depends on the actual organism, preparation, use and applicable tariff and control lists.
Where a microorganism falls within a controlled category, the exporter must establish whether authorization is required.
13. Practical Compliance Framework for Importers and Exporters
Businesses involved in international biological-material transportation should adopt a documented classification procedure.
Recommended compliance workflow
Identify the biological material
Establish whether the shipment contains human, animal, microbial or processed biological material.
Determine its physical condition
Identify whether it is living, frozen, cryopreserved, preserved, processed or prepared.
Determine its intended purpose
Establish whether it is intended for diagnosis, transplantation, fertility treatment, pharmaceutical production or scientific research.
Select the correct TN VED code
Apply the General Rules for Interpretation and the relevant chapter notes.
Check non-tariff restrictions
Examine EEC Decision No. 30, Section 2.21, and any other relevant restrictions.
Conduct export-control screening
Examine Federal Law No. 183-FZ and the applicable control lists.
Obtain necessary authorization
Secure applicable licences, regulatory conclusions and certificates before shipment.
Complete customs declaration
Ensure the customs description, classification, documents and declared purpose are consistent.
14. Major Legal Challenges
Several challenges continue to affect customs classification of biological materials in Russia.
1. Classification uncertainty: Biological samples can fall under different tariff headings depending on their characteristics and preparation.
2. Scientific complexity: Customs officers may not possess sufficient technical knowledge to distinguish between tissue samples, cell cultures, pharmaceutical preparations and diagnostic reagents.
3. Dual-use concerns: Biological samples intended for scientific research may raise export-control questions.
4. Inconsistent documentation: A commercial invoice may describe a material differently from the laboratory certificate or regulatory authorization.
5. Cross-border fertility treatment: The transportation of frozen reproductive cells and embryos creates complicated customs and healthcare compliance questions.
6. Technological development: Synthetic biology, cellular agriculture, genomic research and advanced cell therapies continually create products that challenge traditional tariff classifications.
7. Regulatory coordination: Customs authorities, Roszdravnadzor, Minpromtorg and export-control authorities may have different responsibilities concerning the same shipment.
15. Critical Legal Analysis
The Russian legal framework demonstrates that customs classification of biological materials is not merely a technical exercise involving the selection of an appropriate tariff code.
It is a multidimensional legal process involving customs law, healthcare regulation, international trade law, export control and biotechnology governance.
Three principles are particularly important.
First, classification must reflect the actual biological identity of the product.
A human tissue sample cannot automatically be classified as a pharmaceutical product simply because it is used in medical treatment or research.
Second, tariff classification does not automatically establish regulatory permission.
An exporter may correctly classify human biological materials but still fail to obtain an authorization required under EAEU or Russian law.
Third, the intended purpose of the shipment can be legally significant.
The Russian court disputes discussed above demonstrate that documentary evidence of medical, diagnostic or scientific purposes can become central to determining whether particular regulatory restrictions or exceptions apply.
Consequently, exporters should not rely exclusively on the customs declaration, commercial invoice or a general regulatory conclusion. They should maintain consistent technical, scientific and legal documentation.
16. Conclusion
Customs classification of biological materials in Russia is governed by a combination of EAEU customs rules and Russian national legislation.
The TN VED EAEU provides the principal classification framework, while EEC Board Decision No. 30 establishes important non-tariff requirements for human organs, tissues, blood and biological samples.
The judicial disputes in Cases А56-36287/2023, А56-36285/2023, А56-36284/2023, А56-36289/2023 and А56-56945/2023 demonstrate the practical importance of accurate product descriptions, appropriate regulatory documentation and separate export-control compliance.
The fundamental legal principle is that correct customs classification, regulatory authorization and export-control compliance are three distinct but interconnected obligations.
Russia's developing biotechnology sector will make these issues increasingly important, particularly in relation to stem-cell therapies, reproductive biotechnology, genetic testing, biological research, cellular agriculture and advanced pharmaceutical manufacturing.
17. Important Legal References and Research Sources
For further academic and legal research, the following primary sources are particularly useful:
EEC Decision No. 30 of 21 April 2015 – regulatory framework for human biological materials.
Section 2.21 – classification of human organs, tissues and biological samples.
Roszdravnadzor – official explanations concerning biological samples.
Case No. А56-36287/2023 – export of human biological materials.
Case No. А56-36285/2023 – medical-purpose documentation and export controls.
Case No. А56-36284/2023 – frozen human biological materials.
Case No. А56-36289/2023 – export of frozen human oocytes.
Case No. А56-56945/2023 – administrative liability under Article 16.3.
Academic qualification: The cited arbitrazh decisions primarily concern export restrictions and export-control compliance, rather than establishing binding judicial tariff classifications for every biological material. Their holdings should be checked against the complete judgments and the legislation in force on the date of the relevant shipment. This is particularly important because EAEU and Russian regulatory provisions have subsequently been amended.
Suggested next research topic: Customs Classification And Export-Control Liability Of Human Genetic Samples In Russia. Detailed Explanation With Case Laws.

comments